Psomagen, Inc. (KOSDAQ:950200)
South Korea · Delayed Price · Currency is KRW 3,115.00
+10.00 (0.32%)
At close: Sep 23, 2026
Psomagen Market Cap
Psomagen has a market cap or net worth of 59.92 billion as of September 25, 2026. Its market cap has decreased by -17.59% in one year.
Market Cap
59.92B
Enterprise Value
58.86B
Revenue
60.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,115.00
ChartMarket Cap Chart
Since July 13, 2020, Psomagen's market cap has decreased from 254.61B to 59.92B, a decrease of -76.47%. That is a compound annual growth rate of -20.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 59.92B | -19.72% |
| Dec 30, 2025 | 74.64B | -4.20% |
| Dec 30, 2024 | 77.91B | -20.59% |
| Dec 28, 2023 | 98.10B | -34.17% |
| Dec 29, 2022 | 149.03B | -12.38% |
| Dec 30, 2021 | 170.10B | -50.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CTCBIO | 72.68B |
| IMGT Co.,Ltd. | 72.43B |
| SunBio,Inc. | 69.02B |
| PanGen Biotech | 65.28B |
| ABION | 60.91B |
| NovMetaPharma | 59.46B |
| TegoScience | 58.21B |
| J2KBIO | 53.86B |